BACKGROUND

Infection from SARS-CoV-2 have transient and long-term complications. Persistent symptoms postrecovery with perceptions of overall physical and mental health status are crucial information to construe on follow-up care.

OBJECTIVE

To describe the clinical profile, general, and mental health outcomes of hospital staff who recovered from COVID-19 at follow-up 12 weeks or more post-convalescent.

METHODS

This was a cross-sectional study on follow-up of hospital staff who recovered from COVID-19. Study population included staff or health care workers of a COVID-19 referral tertiary hospital, who had laboratoryconfirmed COVID-19 via RT-PCR. Informed consent was obtained through phone calls and google forms. Data collection was through a self-administered, on-line google form or voice-call interviewer-assisted questionnaire. Analysis was done with Stata 17 using frequencies, proportions, and cross-tabulations.

RESULTS

Persistent symptoms reported several months post-recovery from COVID-19 included fatigue (25%), difficulty of breathing (23%), muscle weakness (16%), nasal congestion (12%), cough (10%), sore throat (5%), anosmia (3%), and ageusia (2%). Symptoms of physical and mental fatigue post-COVID-19 were reported by 25% (N = 93) with extreme fatigue reported by four staff. Fifteen percent (N = 57) reported that they feel that their workload or schedule needed modification after recovery. Feelings of isolation, depression, and anxiety were the most common mental health issues reported. Screening using validated tools showed that depressive symptoms were present in 45% (N = 145) and anxiety in 18% (N = 53).

CONCLUSION

Healthcare workers who recovered from COVID-19 for at least 12 weeks or more described their health status as comparable to their overall health one year before the infection. Physical and mental health symptoms reported 12 weeks post-recovery include fatigue, breathlessness, anxiety, and depression and were described in various levels of severity.

Covid-19

OBJECTIVE

Epidemiological studies on the prevalence and management of depression are limited in the Philippines. This review aimed to assess the prevalence of depression in the Philippines and explore the distribution of patient journey touchpoints including awareness, screening, diagnosis, treatment, adherence, and remission of depression.

METHODS

A structured literature search was conducted in the Medline, Embase, Biosis, and HERDIN PLUS databases to identify records published in English between 01 January 2010 and 31 December 2019 that reported key patient journey touchpoints in depression management in the Philippines. An unstructured literature search was conducted in public or government websites with no date restriction. Data from all sources were extracted and presented descriptively.

RESULTS

Of the 348 records retrieved, one article was included in the final analysis. The prevalence of depression was reported to be 3.34% in the Philippines. There was no data available on any of the identified patient journey touchpoints in depression.

CONCLUSION

The study findings highlight the need for more evidence-based studies in the Philippines to accurately understand the complexity of patient journey in patients with depression. This in turn can help in optimizing resource utilization, providing guidance for clinical practice, and health care reforms in the Philippines.

Depression ; Prevalence ; Philippines

Objectives: A recent review on the status of Philippine ethnobotany showed the lack of ethnobotanical studies in the Visayas group of islands. The use of medicinal plants by the Eskaya, an Indigenous ethnic group in the province of Bohol in Visayas, Philippines, has not yet been documented. This study determines the ethnomedicinal knowledge of traditional healers in selected Eskaya communities in Bohol. Methods: Fifteen (15) Eskaya traditional healers were interviewed using a structured questionnaire, and the valuable medicinal plant species were identified through guided field walks. Informal group discussions with the community were also conducted. Moreover, the fidelity level, informant consensus factor (ICF), and use values (UV) were calculated. Results: Our results showed that the majority of the Eskaya healers belong to an older age group (38 – 71 years old). Eighty-five medicinal plants recorded belong to 44 plant families—with Family Lamiaceae having the highest number of species represented. The leaf is the most common plant part used for healing. Blumea balsamifera was an essential plant with a UV of 0.8. Cardiovascular diseases have the highest ICF values of 0.6, and the most common plants used for these diseases include Cymbopogon citratus, Zingiber officinale, and Luffa cylindrica. Conclusion Our study yielded a record of native and non-native medicinal plants used by the Eskaya healers. This initial listing is also their contribution to promoting medicinal plants that are accessible and abundant in their communities.
ethnobotany ; ethnopharmacology ; herbal medicine ; Philippines ; traditional medicine